cxosTM MOLECULAR COMPLEX

A technological innovation

SCIENTIFIC AND MEDICAL BASES

Latest dermo-cosmetic care products from medical research:

Medical research and innovation are an integral part of OSCIENCE's mission: the brand was created following a major scientific breakthrough that is becoming the benchmark for tissue preservation and repair in a therapeutic setting. This great scientific discovery was born after 7 years of research: it is currently the only technology capable of optimizing the preservation and repair of the cornea of the eye intended for transplantation: the number of cornea retained for the increased from 18% to 75%.


This is a novel technological advance for surgeons who currently use it for its incredible quality and reconstructive effectiveness. It is this innovative repair technology that gave birth to our totally innovative dermo-cosmetic active ingredient: the CXOS ™ molecular complex.

CXOS™ : TECHNOLOGICAL INNOVATION

allows cell reconstruction by creating the micro-environment conducive to intercellular communication.

Like the human corneal conservation media, the CXos ™ molecular complex ensures cell conservation, regulation of cell exchanges and the restructuring of cells to compensate for cell losses, basing its action on the principle of osmolarity and stabilizing the micro-environment of the cells.


When the skin is young the cells are full of water and produce all the essential elements necessary for their activity and the maintenance of their structure. Over time, the microenvironment of the cells deteriorates, leading to a decrease in their water potential. The cells become "atrophied" and can no longer communicate with each other, thereby greatly reducing their activity.


Our technology restores the natural balance and activity of cells by working on their micro-environment and their water potential. Physiologically, this results in the action of electrolytes and enzymatic cofactors to retain functional cells, restart their activity and restore intercellular communication.

CLINICAL STUDIES

Clinical studies n°1

  1. Objective of the test

    To evaluate after 28 days of use, the anti-wrinkle effectiveness of the cream formula containing the molecular complex Cxos ™

  2. METHODS
    • 2.1. Period of study

      28 days

    • 2.2. Experimental design

      Study carried out in open and intra-individual on 21 volunteers, twice-daily application.

    • 2.3. Evaluation criteria

      Study of the variations of the different parameters of the cutaneous relief using the Skin Image Analyzer®.

  3. RESULTS   

Clinical studies n°2

  1. OBJECTive of the test

    Evaluate the subjective appreciation of its organoleptic characteristics and the effectiveness of the cream formula containing the molecular complex CXos ™.

  2. METHODS
    • 2.1. Period of study

      28 days

    • 2.2. Experimental design

      Study carried out in open and intra-individual on 21 volunteers, twice-daily application.

    • 2.3. Evaluation criteria

      Analysis of the responses given by the volunteers to a subjective evaluation questionnaire.

  3. RESULTS